Cargando…

NSE from diffuse large B-cell lymphoma cells regulates macrophage polarization

Background/aims: Diffuse large B-cell lymphoma (DLBCL) is a highly common type of malignant and heterogeneous non-Hodgkin’s lymphoma. Tumor-associated macrophages, specially the M2-type, promote tumor progression and drug resistance. The clinical outcome of patients with high neuron-specific enolase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Meng-yuan, Liu, Wen-jian, Wang, Hua, Wang, Wei-da, Liu, Na-wei, Lu, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529732/ https://www.ncbi.nlm.nih.gov/pubmed/31191019 http://dx.doi.org/10.2147/CMAR.S203010

Ejemplares similares

The Dark Side of Pyroptosis of Diffuse Large B-Cell Lymphoma in B-Cell Non-Hodgkin Lymphoma: Mediating the Specific Inflammatory Microenvironment
por: Wang, Wei, et al.
Publicado: (2021)

AtNSE1 and AtNSE3 are required for embryo pattern formation and maintenance of cell viability during Arabidopsis embryogenesis
por: Li, Gang, et al.
Publicado: (2019)

A role of the Nse4 kleisin and Nse1/Nse3 KITE subunits in the ATPase cycle of SMC5/6
por: Vondrova, Lucie, et al.
Publicado: (2020)

Gut Microbiota in Untreated Diffuse Large B Cell Lymphoma Patients
por: Yuan, Li, et al.
Publicado: (2021)

Metadherin Contributes to the Pathogenesis of Diffuse Large B-cell Lymphoma
por: Ge, Xueling, et al.
Publicado: (2012)

Gemcitabine, oxaliplatin and dexamethasone (GemDOx) as salvage therapy for relapsed or refractory diffuse large B-cell lymphoma and peripheral T-cell lymphoma
por: Shen, Qiu-Dan, et al.
Publicado: (2021)

CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis
por: Huang, Yao-Hui, et al.
Publicado: (2021)

Primary breast diffuse large B-cell lymphoma in the era of rituximab
por: Zhang, Na, et al.
Publicado: (2016)

Rapid identification of novel independent serum biomarkers in diffuse large B-cell lymphoma
por: Che, Yi-Qun, et al.
Publicado: (2020)

Analysis of the Nse3/MAGE-Binding Domain of the Nse4/EID Family Proteins
por: Guerineau, Marc, et al.
Publicado: (2012)

Ovary involvement of diffuse large B-cell lymphoma
por: Hu, Rong, et al.
Publicado: (2012)

Primary hepatic diffuse large B cell lymphoma: A case report: Primary hepatic diffuse large B cell lymphoma
por: Ma, Yuan-Ji, et al.
Publicado: (2011)

Enhanced Expression of Neuron‐specific Enolase (NSE) in Pyothorax‐associated Lymphoma (PAL)
por: Nakatsuka, Shin‐ichi, et al.
Publicado: (2002)

Immunogenomic-Based Analysis of Hierarchical Clustering of Diffuse Large Cell Lymphoma
por: Wang, Longhao, et al.
Publicado: (2022)

Transcriptome integration analysis and specific diagnosis model construction for Hodgkin's lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma
por: Li, Wen-Xing, et al.
Publicado: (2021)

Primary diffuse large B-cell lymphoma of orbit: A population-based analysis
por: Chen, Yu-Qing, et al.
Publicado: (2022)

Asparagine synthetase expression is associated with the sensitivity to asparaginase in extranodal natural killer/T-cell lymphoma in vivo and in vitro
por: Liu, Wen-jian, et al.
Publicado: (2018)

The diagnostic value of serum CEA, NSE and MMP-9 for on-small cell lung cancer
por: Xu, Liu, et al.
Publicado: (2016)

Molecular Heterogeneity in Localized Diffuse Large B-Cell Lymphoma
por: Qin, Wei, et al.
Publicado: (2021)

Expression of Tryptophan Metabolism Enzymes in Patients with Diffuse Large B‐cell Lymphoma and NK/T‐cell Lymphoma
por: Guo, Dan, et al.
Publicado: (2023)

GM-CSF enhanced the effect of CHOP and R-CHOP on inhibiting diffuse large B-cell lymphoma progression via influencing the macrophage polarization
por: Zhang, Yu, et al.
Publicado: (2021)

Leukemic Phase of CD5+ Diffuse Large B-Cell Lymphoma
por: Hsiao, Hui-Hua, et al.
Publicado: (2018)

Differential diagnosis of sinonasal extranodal NK/T cell lymphoma and diffuse large B cell lymphoma on MRI
por: Chen, Yun, et al.
Publicado: (2020)

Diabetes mellitus predicts inferior survival in diffuse large B-cell lymphoma: a propensity score-matched analysis
por: Gao, Rui, et al.
Publicado: (2019)

Influence of Hyperglycemia on the Prognosis of Patients with Diffuse Large B-Cell Lymphoma
por: Zhou, Weiling, et al.
Publicado: (2022)

Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
por: Li, Peifeng, et al.
Publicado: (2021)

Identification of a prognostic metabolic gene signature in diffuse large B‐cell lymphoma
por: Wang, Huizhong, et al.
Publicado: (2021)

USP21 promotes cell proliferation by maintaining the EZH2 level in diffuse large B‐cell lymphoma
por: Ma, Huixian, et al.
Publicado: (2021)

Targetable Metabolic Vulnerability in Diffuse Large B-Cell Lymphoma
por: Xiong, Jie, et al.
Publicado: (2018)

Value of NSE and S100 Protein of Kawasaki Disease with Aseptic Meningitis in Infant
por: Wang, Jiangtao, et al.
Publicado: (2019)

An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment
por: Liang, Xiao-Jie, et al.
Publicado: (2021)

Primary breast diffuse large B cell lymphoma
por: Guo, Mengni, et al.
Publicado: (2022)

BTK kinase activity is dispensable for the survival of diffuse large B-cell lymphoma
por: Yuan, Hongwei, et al.
Publicado: (2022)

Baseline (18)F-FDG PET/CT radiomics for prognosis prediction in diffuse large B cell lymphoma
por: Jing, Fenglian, et al.
Publicado: (2023)

Efficacy of salvage radiotherapy for relapsed/refractory diffuse large B-cell lymphoma
por: Wang, Shu-Bei, et al.
Publicado: (2019)

Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide
por: Yan, Tao, et al.
Publicado: (2011)

Central nervous system involvement of primary renal lymphoma with diffuse large B-cell type lymphoma
por: Hu, Rong, et al.
Publicado: (2013)

Expression of IL‐34 correlates with macrophage infiltration and prognosis of diffuse large B‐cell lymphoma
por: Noyori, Osamu, et al.
Publicado: (2019)

Novel HDAC inhibitor Chidamide synergizes with Rituximab to inhibit diffuse large B-cell lymphoma tumour growth by upregulating CD20
por: Guan, Xu-Wen, et al.
Publicado: (2020)

Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma
por: Zhang, Wei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_reknaoeka5slc0u3dgj9nhr7bj